Highbridge Capital Management LLC has filed its 13F form on May 12, 2025 for Q1 2025 where it was disclosed a total value porftolio of $462 Million distributed in 253 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Ishares Russell 2000 ETF with a value of $93.4M, Hess Corp with a value of $84.2M, Allete Inc with a value of $54.9M, Frontier Communications Parent, Inc. with a value of $40M, and Amedisys Inc with a value of $30.4M.
Examining the 13F form we can see an increase of $26.7M in the current position value, from $435M to 462M .
Highbridge Capital Management LLC is based out at New York, NY
Below you can find more details about Highbridge Capital Management LLC portfolio as well as his latest detailed transactions.
Portfolio value
$462 Million
$112 Million
$93.7 Million
$63 Million
$55 Million
$54.9 Million
$41.5 Million
$34.5 Million
$4.6 Million
$1.57 Million
Stock Market Cap.
Holding Value (Reported)
# of Shares.
Last Trade
Trade History
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 13.82%
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 12.41%
Co2 Energy Transition Corp
-
$0
0.0% of portfolio
-
Q1 2025
New
Co2 Energy Transition Corp
-
$0
0.0% of portfolio
-
Q1 2025
New
Churchill Capital Corp Ix
-
$0
0.0% of portfolio
-
Q4 2024
Reduced 96.0%
Checkpoint Therapeutics Inc
-
$0
0.0% of portfolio
-
Q1 2025
New
Charlton Aria Acquisition CO
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q1 2025
Added 23.48%
Centurion Acquisition Corp
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 6.0%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 0.74%
Black Hawk Acquisition Corp
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 6.13%
-
$0
0.0% of portfolio
-
Q1 2025
Added 3.02%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 29.26%
-
$0
0.0% of portfolio
-
Q1 2025
Added 50.0%
Alnylam Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 7.5%
-
$0
0.0% of portfolio
-
Q1 2025
Added 38.5%
Alchemy Invts Acquisitn Corp
-
$0
0.0% of portfolio
-
Q1 2025
Reduced -0.0%
-
$0
0.0% of portfolio
-
Q1 2025
Added 94.99%
Aimei Health Technology CO L
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 0.14%
Ai Transn Acquisition Corp
-
$0
0.0% of portfolio
-
Q3 2024
Added 9.5%
Agriculture & Nat Sol Acq CO
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 23.26%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 1.36%
-
$0
0.0% of portfolio
-
Q3 2024
Reduced 16.13%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 0.95%
Aa Mission Acquisition Corp
-
$0
0.0% of portfolio
-
Q3 2024
New
Alphatime Acquisition Corp
-
$0
0.0% of portfolio
-
Q1 2023
Reduced 73.63%
Alphavest Acquisition Corp
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 0.29%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 75.26%
-
$0
0.0% of portfolio
-
Q1 2025
Added 37.17%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 0.07%
-
$0
0.0% of portfolio
-
Q1 2025
Added 11.11%
-
$0
0.0% of portfolio
-
Q1 2025
Added 110.51%
Aspire Biopharma Hldgs Inc
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 80.01%
Archimedes Tech Spac Partner
-
$0
0.0% of portfolio
-
Q1 2025
New
$0
$7,000
0.0% of portfolio
771,853
Q1 2025
Reduced 44.63%
Andretti Acquisition Corp Ii
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 63.8%
-
$0
0.0% of portfolio
-
Q1 2025
Added 8.39%
Ambipar Emergency Response
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 0.47%
A Spac Iii Acquisition Corp
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 42.31%
Iron Horse Acquisitions Corp
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 15.42%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 0.55%
-
$0
0.0% of portfolio
-
Q1 2025
Added 5.74%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 24.31%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 20.0%
Haymaker Acquisition Corp Iv
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 23.47%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 74.61%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 48.61%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 37.3%
